Initiator Pharma A/S

OM:INIT Stock Report

Market Cap: kr472.0m

Initiator Pharma Management

Management criteria checks 2/4

Initiator Pharma's CEO is Claus Olesen, appointed in May 2016, has a tenure of 7.67 years. directly owns 2.03% of the company’s shares, worth SEK9.57M. The average tenure of the management team and the board of directors is 8.2 years and 5.5 years respectively.

Key information

Claus Olesen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure8yrs
CEO ownership2.0%
Management average tenure8.2yrs
Board average tenure5.5yrs

Recent management updates

Recent updates

Health Check: How Prudently Does Initiator Pharma (STO:INIT) Use Debt?

Feb 27
Health Check: How Prudently Does Initiator Pharma (STO:INIT) Use Debt?

Is Initiator Pharma (STO:INIT) Using Debt In A Risky Way?

May 20
Is Initiator Pharma (STO:INIT) Using Debt In A Risky Way?

Is Initiator Pharma (STO:INIT) Using Debt In A Risky Way?

Jan 06
Is Initiator Pharma (STO:INIT) Using Debt In A Risky Way?

We're Not Worried About Initiator Pharma's (STO:INIT) Cash Burn

Oct 26
We're Not Worried About Initiator Pharma's (STO:INIT) Cash Burn

We're Not Very Worried About Initiator Pharma's (NGM:INIT) Cash Burn Rate

Jun 12
We're Not Very Worried About Initiator Pharma's (NGM:INIT) Cash Burn Rate

CEO

Claus Olesen (49 yo)

8yrs

Tenure

Dr. Claus Elsborg Olesen is Chief Executive Officer at Stipe Therapeutics. He serves Chief Executive Officer at Initiator Pharma A/S since May 02, 2016 and serves as its Director since September 19, 2016 a...

Leadership Team

NamePositionTenureCompensationOwnership
Claus Olesen
Co-Founder8yrsno data2.03%
DKK 9.6m
Dan Peters
Co-Founder & CTO8.3yrsno datano data
Ulf Simonsen
Co-Founderno datano data1.17%
DKK 5.5m
Mikael Thomsen
Co-Founder & Chief Development Officerno datano data1.34%
DKK 6.3m
Torgeir Vaage
Chief Financial Officer8.3yrsno datano data
Allan Wehnert
Senior Vice President of Clinical and R&D Strategy & Portfolio Management3.4yrsno datano data
Susanne Thomsen
Head of Clin Opsno datano datano data
Rene Egebro
Head of CMCno datano datano data

8.2yrs

Average Tenure

59yo

Average Age

Experienced Management: INIT's management team is seasoned and experienced (8.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Claus Olesen
Co-Founder7.7yrsno data2.03%
DKK 9.6m
Gunnar Magnus Severus Persson
Chairman of the Board of Directors7.7yrsno data0.49%
DKK 2.3m
Henrik Moltke
Director7.7yrsno data0.24%
DKK 1.1m
Irwin Goldstein
Member of Scientific & Clinical Advisory Board3.4yrsno datano data
Gunilla Ekstrom
Independent Director1.6yrsno data0.013%
DKK 62.4k
Annette Colin
Director3.3yrsno data0.65%
DKK 3.1m
Peter Holm
Director7.7yrsno datano data
Sue Goldstein
Member of Scientific & Clinical Advisory Board3.4yrsno datano data

5.5yrs

Average Tenure

60.5yo

Average Age

Experienced Board: INIT's board of directors are considered experienced (5.5 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.